Skip to main content
48°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
January 31, 2022
Tickers
ALGN
ARCT
AZEK
BAH
Tags
MCHP
ARCT
Analyst Ratings
From
Benzinga
Analyst Ratings For Intellia Therapeutics
January 31, 2022
Tickers
NTLA
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
A Deep Dive Into the Video Game Industry
January 29, 2022
Tickers
AAL
AAPL
AMZN
ATVI
Tags
UAL
AMZN
AAL
From
Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
Tickers
BNTX
CURLF
EDIT
GILD
Tags
BNTX
GILD
MRNA
From
Motley Fool
5 Charts to Remember if the Stock Market Crashes in 2022
January 19, 2022
Tickers
CSCO
MRNA
NTLA
TSLA
Tags
MRNA
Recent Press Releases
NTLA
From
Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
Tickers
BEAM
CRSP
NTLA
PFE
Tags
BEAM
Market News
PFE
From
Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, Here's How Much You Would Have Today
January 13, 2022
Tickers
NTLA
Tags
Dividends
BZI/POD
News
From
Benzinga
"Motley Fool Money" 2022 Investing Preview
January 07, 2022
Tickers
AAPL
AFRM
AI
AMWL
Tags
CCI
PTON
WIX
From
Motley Fool
What 4 Analyst Ratings Have To Say About Intellia Therapeutics
January 07, 2022
Tickers
NTLA
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Tickers
ACVA
AER
AIN
ALC
Tags
BEP
DNA
HSIC
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 05, 2022
Tickers
ACRX
ATXI
HOTH
KPRX
Tags
Benzinga
Movers
SMFR
From
Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
Tickers
ALGN
NTLA
REGN
SAVA
Tags
REGN
SAVA
Recent Press Releases
From
Motley Fool
Better Buy: CRISPR vs. Intellia
January 03, 2022
Tickers
BLUE
CRSP
NTLA
REGN
Tags
REGN
CRSP
VRTX
From
Motley Fool
Top 5 Moonshots for 2022 Countdown: My No. 5 Pick
December 22, 2021
Tickers
BEAM
BTU
CRSP
EBAY
Tags
NTLA
SQUID/USD
SAFEMOON/USD
From
InvestorPlace
3 Healthcare Stocks That Could Double Next Year
December 10, 2021
Tickers
ALGN
ISRG
NTLA
Tags
Recent Press Releases
NTLA
ALGN
From
Motley Fool
54 Biggest Movers From Yesterday
December 08, 2021
Tickers
ADAG
ADGI
AERI
ARQQ
Tags
YELL
BYSI
PIII
From
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
December 07, 2021
Tickers
AERI
AVAV
BIRD
BYSI
Tags
Small Cap
AVAV
YELL
From
Benzinga
Direxion Launches New Nanotechnology ETF, TYNE
November 23, 2021
Tickers
ALKS
ANGO
ARCT
BEAM
Tags
MRNA
ARCT
BNTX
From
ETF Trends
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
November 21, 2021
Tickers
CRSP
NTLA
Tags
Recent Press Releases
NTLA
Market News
From
Motley Fool
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
NVO
Health Care
NTLA
From
Benzinga
Intellia Therapeutics, Inc (NTLA) Q3 2021 Earnings Call Transcript
November 06, 2021
Tickers
NTLA
Tags
NTLA
Recent Press Releases
Market News
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
ILMN
IRWD
QDEL
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
EYEN
IPOs
ENDP
From
Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
Tickers
CRSP
NTLA
REGN
VRTX
Tags
REGN
VRTX
CRSP
From
Motley Fool
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
Tickers
ARKG
BEAM
DIS
EXAS
Tags
NVO
EXAS
JNJ
From
Motley Fool
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
NASDAQ:EDIT,NASDAQ:NTLA
Market News
NTLA
From
InvestorPlace
EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock
October 18, 2021
Tickers
NTLA
Tags
David Lebwohl
Trading Ideas
Benzinga
From
Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
Tickers
ARKG
ARKK
BEAM
CRSP
Tags
ARKG
BEAM
VERV
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
SDGR
BEAM
Market News
From
Motley Fool
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
October 15, 2021
Tickers
BLFS
EDIT
LZAGF
MRNA
Tags
NVS
Market News
MRNA
From
Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.